Article Text

P3.100 High mycoplasma genitalium prevalence in chlamydia trachomatis positive patients
  1. Dirks JAMC1,2,
  2. Wolffs PFG1,
  3. Dukers-Muijrers NHTM2,
  4. Hoebe CJPA1,2
  1. 1Department of Medical Microbiology, School of Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands
  2. 2Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service (GGD), Geleen, The Netherlands


Introduction: Mycoplasma genitalium (MG) is increasingly seen as a clinically relevant sexually transmitted infection (STI), with a clinical spectrum similar to Chlamydia trachomatis (CT) and Neisseria gonorhoeae, including pelvic inflammatory disease and adverse reproductive outcomes. In the Netherlands, MG testing is not currently recommended for first-line STI screening despite a~4% background prevalence. Very little is known about co-infections with CT or NG as patients are usually only tested after negative CT/NG tests. We therefore studied the co-occurrence of MG and CT in both low- and high-prevalence populations.

Methods 1024 CT-positive participants from the Dutch general population (participants in the Chlamydia Screening Intervention-study) (60.3%; 462 ♀) and STI-clinic in South Limburg, the Netherlands (39.6%; 259 ♀) were retrospectively tested for MG. Men provided urine samples and women self-collected vaginal swabs. Samples were tested for human cells to ensure adequate sampling. CT/MG co-infections were investigated and correlated to symptoms. Statistical testing was performed using Chi-square test.

Results Of 1024 CT-positive patients, 5.5% had a co-infection with MG. CT/MG co-infections were present in 6.3% of the general population, compared to 4.2% of STI-clinic visitors. 3.9% of STI-clinic women had a CT/MG co-infection, compared to 7.4% in the general population. STI-clinic and general population men had a similar MG prevalence of 3.2% and 4.7%. Symptoms were reported by 37.3% of patients; 37.2% in single CT-infections and 39.3% in CT/MG co-infections.

Conclusion CT/MG co-infections are at least as common (5.5%), and in some populations more common (up to 7.4%), than in the general (CT-negative) population. As MG-testing is currently not routine practice in most clinics, these women go undiagnosed and receive inferior treatment, which likely contributes to current 30%–45% azithromycin resistance in MG. However, the higher prevalence of MG in the general population and the similar frequency of symptoms in both groups questions the clinical relevance of this pathogen.

Statistics from

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.